Solorank.ai
Cached score snapshot
US.HSIC · Henry Schein
110分制 61/110；5D動能v2 5/50；排序分 66/160
Score breakdown
觀望
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | 歷史相似情境上漲比例 | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | +0.72% | -1.36% / +2.29% | 60% | 0% | Actual -0.82% · vs median -1.54% · inside 25-75 band |
| 30D observation | +7.45% | +0.86% / +12.78% | 78.8% | 6.3% | Actual outcome pending · 1 / 30 bars observed |
| Historical projection 10D n=160 | +0.54% | -1.38% / +2.47% | 56.9% | 1.9% | Actual outcome pending · 1 / 10 bars observed |
歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。
2026-05-22 → 2026-09-29 · 173 archived points · 2 Improving turn signal · 4 Deteriorating signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Ranking score
66
Display grade
觀望
Model version
cursor_18_27_news_v2_160
Main score
61/110 (觀望)
5D momentum v2
5/50 (弱)
Score with momentum v2
66/160 (低排序)
Risk level
Medium
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 21.9 · 市場環境 12 · 5D動能v2 5
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Market inputs
Bar count
60
ma20
87.5045
ma50
85.0522
close
89.23
prevClose
89.52
avgVolume20
1353278
volumeRatio
0.61
changePercent
-0.32
Metrics snapshot
close
89.23
volume
825150
changePercent
-0.32
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
Main score
61/110
Main rating
觀望
5D momentum v2
5/50
Score with momentum v2
66/160
Formula
score_with_momentum_v2 = main_score + momentum_5d_v2_score
基本面 — 2.3/5 · 較差
Dimension score
2.3/5
Dimension grade
較差
Sub-items
pbPoints
0.4
pePoints
0.2
epsPoints
0
roePoints
0.4
debtPoints
0.4
marginPoints
0
turnoverUsdM
73.6281
volumePoints
0.5
revenuePoints
0
dividendPoints
0
marketCapPoints
0.4
資金流 — 10/20 · 較差
Dimension score
10/20
Dimension grade
較差
Sub-items
cmfPoints
0.8
mfiPoints
2.4
obvPoints
0.8
vwapPoints
4
institutional
score
2
details
source
optional-neutral
warning
code
INSTITUTIONAL_DATA_OPTIONAL
symbol
US.HSIC
message
Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional
true
holderCount
n/a
holderPoints
2
top10ShareRatio
n/a
concentrationPenalty
0
institutionPoints
2
市場環境 — 12/15 · 優秀
Dimension score
12/15
Dimension grade
優秀
Sub-items
vix
score
2.4
details
source
twelvedata+fred
vixClose
15.19
trend
score
3.4
details
qqq
ma20
706.243
ma50
712.9844
name
QQQ
close
717.51
points
1.4
spy
ma20
758.684
ma50
749.836
name
SPY
close
767.45
points
2
source
twelvedata+fred
atrPct
2.5572
atrPoints
3
cciPoints
3.2
vixPoints
2.4
marketTrendPoints
3.4
催化劑 — 2/20 · 較差
Dimension score
2/20
Dimension grade
較差
Sub-items
catalyst
score
2
details
source
finnhub_news_keyword_model
articleCount
8
catalystCount
0
catalystPoints
2
風險管理 — 6.8/10 · 一般
Dimension score
6.8/10
Dimension grade
一般
Sub-items
position
score
1.4
details
atrPct
2.5572
turnoverUsdM
73.6281
liquidityPoints
0.4
volatilityPoints
1
rrPoints
1.6
stopLevels
symbol
US.HSIC
rr_range
1:1.0-1:2.5
risk_profile
中等
stop_loss_price
84.6664
strength_details
ma_score
1.5
atr_score
2
rsi_score
3
macd_score
3
volume_score
1
market_adjustment
1
risk_reward_ratio
1.6
stop_loss_percent
5.1
take_profit_price
96.4253
target_multiplier
2.2
technical_strength
2.15
take_profit_percent
8.1
positionPoints
1.4
stopLossPoints
1.8
diversification
score
2
details
method
sector concentration proxy; no portfolio holdings used
sector
Health Care
concentratedSectorPenalty
0
riskRewardRatio
1.5838
stopLossPercent
5.1144
diversificationPoints
2
技術信號 — 21.9/30 · 良好
Dimension score
21.9/30
Dimension grade
良好
Sub-items
bbPoints
3
adxPoints
3
sarPoints
2.4
vcpPoints
2.2
macdPoints
4
vcpPayload
vcp_pass
false
vcp_score
2.2
vcp_reason
波幅收縮(11%→5.7%)；跌縮量(近10日5日)；站上MA50；Ready=Y；Confirm=N
vcp_metrics
up_days
3
vol_ref
1344923.3333
down_days
6
vcp_ready
true
above_ma50
true
avg_vol_10
1356270
avg_vol_20
1369540
avg_vol_30
1344923.3333
range_pct_10
0.0574
range_pct_20
0.1008
range_pct_30
0.1103
up_expand_ok
false
lookback_used
59
near_20d_high
true
contraction_ok
true
down_shrink_ok
true
up_expand_days
1
breakout_20d_ok
false
vol_ratio_10_30
1.0084
dist_to_20d_high
0.032
down_shrink_days
5
breakout_level_20d
92.18
vcp_breakout_confirm
false
contraction_ratio_10_30
0.5203
vcp_name_en
Volatility Contraction Pattern
vcp_name_zh
波動收縮形態
vol_contraction
true
kdjAdxPoints
0.5
rsiKdjPoints
2.4
volumeWeight
2
maCrossPoints
1.6
shortRsiPoints
1
shortMacdPoints
0.4
volConfirmPoints
1
volumePointsTechnical
0.4
情緒分析 — 6/10 · 一般
Dimension score
6/10
Dimension grade
一般
Sub-items
sentiment
score
6
details
source
finnhub_news_keyword_model
articleCount
8
negativeHits
0
positiveHits
4
sentimentScoreRaw
1.2
sentimentData
raw
{"id":141202797,"url":"https://finnhub.io/api/news?id=13ce48a78662402c8da575e857e238a83c262f9699386bfe1a70946f69834569","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Cloud-based dental software drives margin expansion and record customer growth.","category":"company","datetime":1786466698,"headline":"Henry Schein (HSIC) Q2 2026 Earnings Call Transcript"}, {"id":141175592,"url":"https://finnhub.io/api/news?id=3ce2efa0a033980499897cbba23f031ed75752404bd62aedd9dbd013c13cbacb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.","category":"company","datetime":1786369204,"headline":"Should Value Investors Buy Henry Schein (HSIC) Stock?"}, {"id":141137536,"url":"https://finnhub.io/api/news?id=ddeba90c97f44d13449db22fa27f761374ca2e34a2f1d31b1902e6b98e9c43ee","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"HSIC vs. SAUHY: Which Stock Is the Better Value Option?","category":"company","datetime":1786030803,"headline":"HSIC or SAUHY: Which Is the Better Value Stock Right Now?"}, {"id":141130014,"url":"https://finnhub.io/api/news?id=77172b533a558640015e733cb2b41e75a28f7d7f54deecf31c06a5bc3a87a165","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Henry Schein, Inc. reported past Q2 2026 results with sales rising to US$3,458 million and net income to US$94 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. Importantly for long-term watchers, management also raised its 2026 total sales growth guidance, signaling greater confidence in the company’s operating initiatives and demand trends. Now we’ll examine how Henry Schein’s raised 2026 sales outlook reshapes its existing...","category":"company","datetime":1785978772,"headline":"Should Henry Schein’s Raised 2026 Sales Growth Guidance Require Action From Henry Schein (HSIC) Investors?"}, {"id":141122797,"url":"https://finnhub.io/api/news?id=b6668726049d5d4ee7e835b96bedc652f6c5701d59f49e0912023e1b5097919d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Henry Schein (HSIC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.","category":"company","datetime":1785935706,"headline":"Henry Schein, Inc. (HSIC) Hits Fresh High: Is There Still Room to Run?"}, {"id":141120510,"url":"https://finnhub.io/api/news?id=acffe16b1c33461b9fbeff72f54a5d2c99b0cc0eb0ecb86a4078f1a3ccdf6b34","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Henry Schein stock has delivered a 37.5% return over the past year, yet the valuation picture is more mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate indicating the shares may be trading at a sizeable discount while earnings based multiples look closer to fair. Henry Schein's 37.5% one year return suggests investors have already priced in a meaningful improvement in the story, so additional upside may depend on how the fundamentals evolve from here. The leadership...","category":"company","datetime":1785924693,"headline":"Is Henry Schein (HSIC) Still Cheap After A 37% Run?"}, {"id":141112261,"url":"https://finnhub.io/api/news?id=e39066518f2c949a94d671ac58f6703a4c60fa7f16a334dfd4a70d38f1918c35","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"HSIC","summary":"Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call August 4, 2026 8:00 AM EDTCompany ParticipantsGraham Stanley - VP of Investor Relations & Strategic...","category":"company","datetime":1785853200,"headline":"Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call Transcript"}, {"id":141110312,"url":"https://finnhub.io/api/news?id=01e5837a924347cd1bedd5dda28d8136eee81b885372098288f763d19df0933a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Henry Schein tops Q2 earnings and revenue estimates as internal sales growth accelerates and management raises its 2026 outlook, lifting shares.","category":"company","datetime":1785850380,"headline":"HSIC Surpasses Q2 Earnings and Revenue Estimates, Stock Climbs"}
raw_source
{"id":141204260,"url":"https://finnhub.io/api/news?id=db58bf0aa8b68ae2fed6dfd6fc95b2a0fbb1d72d2a6aad32521464e16841a36e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Henry Schein delivered a positive second quarter, with results exceeding Wall Street’s expectations and earning a strong market response. Management attributed the outperformance to accelerating internal sales growth, robust gains in its global dental merchandise segment, and early benefits from value creation initiatives. CEO Frederick Lowery emphasized the company’s success in converting occasional buyers into engaged customers and highlighted strong market share gains, particularly in the U.S","category":"company","datetime":1786611180,"headline":"5 Insightful Analyst Questions From Henry Schein’s Q2 Earnings Call"}, {"id":141202797,"url":"https://finnhub.io/api/news?id=13ce48a78662402c8da575e857e238a83c262f9699386bfe1a70946f69834569","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Cloud-based dental software drives margin expansion and record customer growth.","category":"company","datetime":1786466698,"headline":"Henry Schein (HSIC) Q2 2026 Earnings Call Transcript"}, {"id":141175592,"url":"https://finnhub.io/api/news?id=3ce2efa0a033980499897cbba23f031ed75752404bd62aedd9dbd013c13cbacb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.","category":"company","datetime":1786369204,"headline":"Should Value Investors Buy Henry Schein (HSIC) Stock?"}, {"id":141137536,"url":"https://finnhub.io/api/news?id=ddeba90c97f44d13449db22fa27f761374ca2e34a2f1d31b1902e6b98e9c43ee","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"HSIC vs. SAUHY: Which Stock Is the Better Value Option?","category":"company","datetime":1786030803,"headline":"HSIC or SAUHY: Which Is the Better Value Stock Right Now?"}, {"id":141136257,"url":"https://finnhub.io/api/news?id=2ac3067fffc80a90c223a89613abecd8a0b4b6c6a85b2f2005c4bc46988c158b","image":"","source":"Benzinga","related":"HSIC","summary":"Barclays analyst Glen Santangelo maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $86 to $100.","category":"company","datetime":1786009168,"headline":"Barclays Maintains Overweight on Henry Schein, Raises Price Target to $100"}, {"id":141130014,"url":"https://finnhub.io/api/news?id=77172b533a558640015e733cb2b41e75a28f7d7f54deecf31c06a5bc3a87a165","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Henry Schein, Inc. reported past Q2 2026 results with sales rising to US$3,458 million and net income to US$94 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. Importantly for long-term watchers, management also raised its 2026 total sales growth guidance, signaling greater confidence in the company’s operating initiatives and demand trends. Now we’ll examine how Henry Schein’s raised 2026 sales outlook reshapes its existing...","category":"company","datetime":1785978772,"headline":"Should Henry Schein’s Raised 2026 Sales Growth Guidance Require Action From Henry Schein (HSIC) Investors?"}, {"id":141136258,"url":"https://finnhub.io/api/news?id=e4ac95fc7fd92c719b305af361c177558bae5f9e4714dd2327f875f43a516150","image":"","source":"Benzinga","related":"HSIC","summary":"UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the price target from $89 to $94.","category":"company","datetime":1785944951,"headline":"UBS Maintains Neutral on Henry Schein, Raises Price Target to $94"}, {"id":141136259,"url":"https://finnhub.io/api/news?id=05e60f86d98d403bfdda4d0ed7349b566cea35e6ed37d4a252ce2cc736e0602b","image":"","source":"Benzinga","related":"HSIC","summary":"Citigroup analyst Daniel Grosslight maintains Henry Schein (NASDAQ:HSIC) with a Buy and raises the price target from $100 to $112.","category":"company","datetime":1785941800,"headline":"Citigroup Maintains Buy on Henry Schein, Raises Price Target to $112"}, {"id":141122797,"url":"https://finnhub.io/api/news?id=b6668726049d5d4ee7e835b96bedc652f6c5701d59f49e0912023e1b5097919d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Henry Schein (HSIC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.","category":"company","datetime":1785935706,"headline":"Henry Schein, Inc. (HSIC) Hits Fresh High: Is There Still Room to Run?"}, {"id":141120510,"url":"https://finnhub.io/api/news?id=acffe16b1c33461b9fbeff72f54a5d2c99b0cc0eb0ecb86a4078f1a3ccdf6b34","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Henry Schein stock has delivered a 37.5% return over the past year, yet the valuation picture is more mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate indicating the shares may be trading at a sizeable discount while earnings based multiples look closer to fair. Henry Schein's 37.5% one year return suggests investors have already priced in a meaningful improvement in the story, so additional upside may depend on how the fundamentals evolve from here. The leadership...","category":"company","datetime":1785924693,"headline":"Is Henry Schein (HSIC) Still Cheap After A 37% Run?"}, {"id":141123305,"url":"https://finnhub.io/api/news?id=ca3dc88e5b266a9bf638da0afc89f49d6eb425b6e4cf1382c99239c6ca409d99","image":"","source":"Benzinga","related":"HSIC","summary":"BTIG analyst David Larsen reiterates Henry Schein (NASDAQ:HSIC) with a Buy and maintains $100 price target.","category":"company","datetime":1785910507,"headline":"BTIG Reiterates Buy on Henry Schein, Maintains $100 Price Target"}, {"id":141120511,"url":"https://finnhub.io/api/news?id=8ae2ad59bc13ad7da2ba186d561098d1982cc1b6ce262d5eb5abac78a8dc4fa6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Moby summary of Henry Schein, Inc.'s Q2 2026 earnings call","category":"company","datetime":1785895753,"headline":"Henry Schein, Inc. Q2 2026 Earnings Call Summary"}, {"id":141118414,"url":"https://finnhub.io/api/news?id=557878f7486aae6f59d5dbbfd9147accc4ff362ed8b242eb402d6d811e268cff","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"HSIC","summary":"2026-08-05. The following slide deck was published by Henry Schein, Inc.","category":"company","datetime":1785891777,"headline":"Henry Schein, Inc. 2026 Q2 - Results - Earnings Call Presentation"}, {"id":141112071,"url":"https://finnhub.io/api/news?id=41789a061b6b09b1b44b9d2c1b4bb5d8baaa4320e5fd430f67f115d56fd21fcc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Henry Schein (NASDAQ:HSIC) reported higher second-quarter sales, operating margins and earnings, citing accelerating internal sales growth, market-share gains in dental merchandise and early benefits from its value-creation program. The company also raised its full-year sales and adjusted earnings g","category":"company","datetime":1785859466,"headline":"Henry Schein Q2 Earnings Call Highlights"}, {"id":141112261,"url":"https://finnhub.io/api/news?id=e39066518f2c949a94d671ac58f6703a4c60fa7f16a334dfd4a70d38f1918c35","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"HSIC","summary":"Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call August 4, 2026 8:00 AM EDTCompany ParticipantsGraham Stanley - VP of Investor Relations & Strategic...","category":"company","datetime":1785853200,"headline":"Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call Transcript"}, {"id":141110312,"url":"https://finnhub.io/api/news?id=01e5837a924347cd1bedd5dda28d8136eee81b885372098288f763d19df0933a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Henry Schein tops Q2 earnings and revenue estimates as internal sales growth accelerates and management raises its 2026 outlook, lifting shares.","category":"company","datetime":1785850380,"headline":"HSIC Surpasses Q2 Earnings and Revenue Estimates, Stock Climbs"}, {"id":141110366,"url":"https://finnhub.io/api/news?id=90cf0c669ec0caf39e573b66bb0383e2eb51f01348b0568fdbfaac3e2a33284c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"While the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.","category":"company","datetime":1785850203,"headline":"Henry Schein (HSIC) Reports Q2 Earnings: What Key Metrics Have to Say"}, {"id":141107921,"url":"https://finnhub.io/api/news?id=5ed00d970d9f0623f40e952eaccbc30ab883a5a63b0952a1a0980a6637262f64","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.","category":"company","datetime":1785844642,"headline":"3 S&P 500 Stocks Walking a Fine Line"}, {"id":141107588,"url":"https://finnhub.io/api/news?id=c861068787cab33bfc4419a04ef8d56e040c452e849c754656552f61bcab932e","image":"https://www.chartmill.com/images/uploads/earnings_article_1_defce97180.webp","source":"ChartMill","related":"HSIC","summary":"Henry Schein Q2 2026: EPS $1.27 beats estimates, revenue $3.46B up 6.7%, raises full-year guidance. Stock up 1.8% premarket.","category":"company","datetime":1785843439,"headline":"Henry Schein (NASDAQ:HSIC) Beats Q2 Estimates and Raises Full-Year Guidance"}, {"id":141108854,"url":"https://finnhub.io/api/news?id=eec0907e2f8b9c8eb9e3bed6f2d93340eec0da9481493f546717a71608474488","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Henry Schein (HSIC) delivered earnings and revenue surprises of +4.10% and +2.80%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1785841801,"headline":"Henry Schein (HSIC) Q2 Earnings and Revenues Beat Estimates"}, {"id":141107939,"url":"https://finnhub.io/api/news?id=676413998ce0f02b1d2d360a1d97681185994ce9f2e02828d88d3de1c5890677","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Dental and medical products company Henry Schein (NASDAQ:HSIC) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 6.7% year on year to $3.46 billion. Its non-GAAP profit of $1.27 per share was 2.5% above analysts’ consensus estimates.","category":"company","datetime":1785839077,"headline":"Henry Schein (NASDAQ:HSIC) Surprises With Q2 CY2026 Sales"}, {"id":141107940,"url":"https://finnhub.io/api/news?id=f94997c1f7c9e609f6893e53e19a861d39af7446d9f767538e7e896a24f29ab4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"MELVILLE, N.Y., August 04, 2026--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, today reported financial results for the second quarter ended June 27, 2026.","category":"company","datetime":1785837600,"headline":"Henry Schein Reports Strong Second Quarter 2026 Financial Results and Raises FY2026 Guidance"}, {"id":141116542,"url":"https://finnhub.io/api/news?id=09e880cb97959b7248932339f244738b136e5c0cb2eedda3e6b4be323ab34735","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=2048&height=1536","source":"Benzinga","related":"HSIC","summary":"Henry Schein (NASDAQ:HSIC) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below.\nThis transcript is brought to you by Benzinga","category":"company","datetime":1785834549,"headline":"Henry Schein Q2 2026 Earnings Call: Complete Transcript"}, {"id":141116543,"url":"https://finnhub.io/api/news?id=fc97cafb9c7e98e1afcace4df2980cfabcb2d7c41fac77843d9b4d8a1de82304","image":"","source":"Benzinga","related":"HSIC","summary":"Henry Schein (NASDAQ:HSIC) raises FY2026 Adj EPS guidance from $5.23-$5.37 to $5.29-$5.39 vs $5.33 analyst estimate. Raises FY2026 sales outlook from $13.580 billion-$13.843 billion to $13.794 billion-$13.926 billion vs","category":"company","datetime":1785823514,"headline":"Henry Schein Raises FY2026 Adj EPS Guidance from $5.23-$5.37 to $5.29-$5.39 vs $5.33 Est; Raises FY2026 Sales Guidance from $13.580B-$13.843B to $13.794B-$13.926B vs $13.738B Est"}, {"id":141116544,"url":"https://finnhub.io/api/news?id=dc4e8d00225fe5bbde0f1c899da2bc19fa7b2d90cdf615283c90683b5a06f864","image":"","source":"Benzinga","related":"HSIC","summary":"Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $1.24 by 2.42 percent. This is a 15.45 percent increase over earnings of $1.10 per share from the","category":"company","datetime":1785823297,"headline":"Henry Schein Q2 Adj. EPS $1.27 Beats $1.24 Estimate, Sales $3.458B Beat $3.375B Estimate"}, {"id":141101308,"url":"https://finnhub.io/api/news?id=97838c038fecc1a81315b3fe6317961a8bfe1e074edbb7dc2969eb4c6bfa10d0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Dental and medical products company Henry Schein (NASDAQ:HSIC) will be reporting results this Tuesday before the bell. Here’s what you need to know.","category":"company","datetime":1785768802,"headline":"Henry Schein (HSIC) Reports Q2: Everything You Need To Know Ahead Of Earnings"}, {"id":141101309,"url":"https://finnhub.io/api/news?id=77217be39d97dcea8961e6629a034c6e95329e6a3a5ff364fafcfceb0ce4fa8b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"The reorganization comes months after Fred Lowery was named CEO and the company deepened its relationship with private equity firm KKR.","category":"company","datetime":1785747600,"headline":"Henry Schein removes 3 longtime execs in leadership shakeup"}, {"id":141077229,"url":"https://finnhub.io/api/news?id=e08362b1d1e763cf9db2c126b7646e46b8ad53c9c194f5f689f9cc18ae6f07b0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.","category":"company","datetime":1785495335,"headline":"1 Cash-Producing Stock to Target This Week and 2 We Question"}, {"id":141064771,"url":"https://finnhub.io/api/news?id=3c8576f4ec21ec742c43320948e5981ba5f156bb1cb19ebdc53660d695e39f6a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"MELVILLE, N.Y., July 30, 2026--Henry Schein, Inc. (Nasdaq: HSIC) announced today that it is creating the Henry Schein Leadership Team (HSLT) to replace its Executive Management Committee. The Company will also integrate its global supply chain organization with its global distribution group. The new leadership structure will continue to develop the Company’s strategic priorities, accelerate its execution, and enhance enterprise collaboration.","category":"company","datetime":1785409200,"headline":"Henry Schein Announces Leadership Transitions"}, {"id":141059462,"url":"https://finnhub.io/api/news?id=02a3f8e041d7c6cc2c5c79b5553e74a1ede0c3508a8071c4ee0b60b4a59c2c42","image":"","source":"Benzinga","related":"HSIC","summary":"Piper Sandler analyst Jason Bednar maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $91 to $95.","category":"company","datetime":1785330948,"headline":"Piper Sandler Maintains Overweight on Henry Schein, Raises Price Target to $95"}, {"id":141050021,"url":"https://finnhub.io/api/news?id=bbaca5dd00a9e9ab05fb272a223cb8e7e5f25c3f79cdafba535b20fdb4e9fa96","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Henry Schein (NASDAQ:HSIC) and its peers.","category":"company","datetime":1785291182,"headline":"Q1 Earnings Roundup: Henry Schein (NASDAQ:HSIC) And The Rest Of The Dental Equipment & Technology Segment"}, {"id":141047793,"url":"https://finnhub.io/api/news?id=7ae08794ee9e1fc9d1e7f8597107a075636e00d89d8e77d9da8f39251a9052c9","image":"","source":"Benzinga","related":"HSIC","summary":"UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the price target from $85 to $89.","category":"company","datetime":1785252144,"headline":"UBS Maintains Neutral on Henry Schein, Raises Price Target to $89"}, {"id":141043753,"url":"https://finnhub.io/api/news?id=26ad68828352e6c29c891a3dfad45b0b89d2bac7a4cc44630baee9cb00c94ea1","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"HSIC heads into Q2 earnings with expectations for revenue and EPS growth as dental, specialty products and AI-enabled technology remain in focus.","category":"company","datetime":1785245100,"headline":"Henry Schein Prepares to Report Q2 Earnings: What's in the Cards?"}, {"id":141033957,"url":"https://finnhub.io/api/news?id=f9c77f2c7a2b30fa8a6e2c19700b09a28d1482789e3ac5a2c0c0cc32cff09d93","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"A steadily shrinking share count and a giant float owed to suppliers are handing owners a bigger slice of the drug distributor each year, even as drug-pricing worries hang over the stock.","category":"company","datetime":1785160469,"headline":"The Buyback Machine Hiding Behind Cardinal Health's Thin Margins"}, {"id":140995071,"url":"https://finnhub.io/api/news?id=8ffc06d98842cfd9894bec94cc65023b1ec1025c6d7b2ceec3f56a00f5bf4ed5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.","category":"company","datetime":1784814004,"headline":"Are Investors Undervaluing Henry Schein (HSIC) Right Now?"}, {"id":140986483,"url":"https://finnhub.io/api/news?id=1fe8f85feaaf866d3f6cd77cac66408d824c381cab208ebb46ea6a8ae7f4e72e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Upcoming earnings release puts focus on Henry Schein stock Henry Schein (HSIC) is back on investors’ radar after announcing it will report second quarter 2026 results before the market opens on August 4, followed by an earnings conference call and webcast. See our latest analysis for Henry Schein. Henry Schein’s recent share price performance has been firmer over the past few months, with a 30 day share price return of 7.43% and a year to date share price return of 11.77%. Meanwhile, the 1...","category":"company","datetime":1784747591,"headline":"Henry Schein (HSIC) Could Be 3% Undervalued As Earnings Come Into Focus"}, {"id":140981940,"url":"https://finnhub.io/api/news?id=4ef76ce27eda81d626046a0e4578b307154512d58d22f0a60cb0d85499f4330a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"LH heads into Q2 earnings results with expectations for higher revenues and EPS, as diagnostics, specialty testing and new collaborations drive momentum.","category":"company","datetime":1784723820,"headline":"Labcorp Prepares to Report Q2 Earnings: What's in the Cards?"}, {"id":140973539,"url":"https://finnhub.io/api/news?id=fc59b28a72e9fb67c5de58ff9b6deef6c4e9908ebb0d5136f53ed8bdb8d7d728","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"WST heads into Q2 earnings with expectations for revenue and EPS growth, backed by demand for biologics and GLP-1 components plus manufacturing gains.","category":"company","datetime":1784647920,"headline":"WST Likely to Beat Q2 Earnings Estimates: How to Play the Stock?"}, {"id":140969661,"url":"https://finnhub.io/api/news?id=9c574e32d1ba87de743c163a5271f334521271294051559f0208df02fabb9c3b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"MELVILLE, N.Y., July 21, 2026--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its second quarter 2026 financial results before the stock market opens on Tuesday, August 4, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Fred Lowery, Chief Executive Officer and Ro","category":"company","datetime":1784629800,"headline":"Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET"}, {"id":140962334,"url":"https://finnhub.io/api/news?id=7cc55104ec9bbc22bbb01fb63ee5ed86574ce6c621c24e9538c50ee030e79d77","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HSIC","summary":"Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.","category":"company","datetime":1784563804,"headline":"Will Henry Schein (HSIC) Beat Estimates Again in Its Next Earnings Report?"}
data_source
finnhub_news_keyword_model
article_count
8
negative_hits
0
positive_hits
4
recomputed_at_score
true
sentiment_score_raw
1.2
source_article_count
40
discarded_article_count
23
sentimentPoints
6
Dimension contribution
Dimension
Raw
Max
Norm %
Contrib
基本面
2.3
5/110
46%
2.3
資金流
10
20/110
50%
10
市場環境
12
15/110
80%
12
催化劑
2
20/110
10%
2
風險管理
6.8
10/110
68%
6.8
技術信號
21.9
30/110
73%
21.9
情緒分析
6
10/110
60%
6
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
5D momentum v2
5/50
ret_5d
0.0006
max_score
50
max_total
50
raw_total
5
vcp_bonus
0
vol_ratio
0.6025
ret_points
4
vol_points
0
range_ratio
0.8146
volat_points
0
day_range_pct
0.0193
model_version
cursor_18_27_news_v2_160
available_bars
30
breakout_points
0
partial_history
false
pullback_points
1
breakout_vol_bonus
0
first_breakout_20d
false
return_window_days
5
first_breakout_bonus
0
breakout_quality_points
0
Risk management
level
Medium
reason
risk management score >= 6.5/10
position
score
1.4
details
atrPct
2.5572
turnoverUsdM
73.6281
liquidityPoints
0.4
volatilityPoints
1
rrPoints
1.6
stopLevels
symbol
US.HSIC
rr_range
1:1.0-1:2.5
risk_profile
中等
stop_loss_price
84.6664
strength_details
ma_score
1.5
atr_score
2
rsi_score
3
macd_score
3
volume_score
1
market_adjustment
1
risk_reward_ratio
1.6
stop_loss_percent
5.1
take_profit_price
96.4253
target_multiplier
2.2
technical_strength
2.15
take_profit_percent
8.1
positionPoints
1.4
stopLossPoints
1.8
diversification
score
2
details
method
sector concentration proxy; no portfolio holdings used
sector
Health Care
concentratedSectorPenalty
0
riskRewardRatio
1.5838
stopLossPercent
5.1144
diversificationPoints
2
Calculation audit log
基本面分析總分: 2.3/5分 資金流分析總分: 10/20分 市場環境分析總分: 12/15分 催化劑分析: 2/20分 風險管理總分: 6.8/10分 技術信號分析總分: 21.9/30分 情緒分析: 6/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
value
85.71
atr
atr
2.2818
rule
ATR / current price; lower volatility scores higher
score
6
atr_pct
2.56
cci
rule
Cursor_18.24 CCI bands
level
適中偏強
score
8
value
67.97
cmf
rule
Cursor_18.24 CMF bands
level
派發
score
2
value
-0.0233
kdj
d
59.29
j
44.43
k
54.34
rule
Cursor_18.24 K/D cross
score
0
signal
死叉
mfi
rule
Cursor_18.24 MFI bands
level
平衡
score
6
value
50.47
obv
rule
Cursor_18.24 recent_slope vs previous_slope
score
2
trend
資金流出
value
17269850
recentSlope
-545175
previousSlope
915630
rsi
value
65.8
sar
rule
Cursor_18.24 Parabolic SAR
score
8
trend
上升
value
86.2635
position
SAR喺價下
distancePct
3.32
previousTrend
上升
ma50
value
85.0522
macd
macd
1.4491
trend
強烈看漲
signal
1.4387
histogram
0.0104
vwap
rule
Cursor_18.24 VWAP 20D consecutive close
score
10
value
87.5053
position
連續5日>VWAP
consecutiveAbove
12
volume
rule
Cursor_18.24 volume ratio
level
空升
ratio
0.61
score
2
avgVolume
1353278
currentVolume
825150
derived
ma20
87.5045
ma50
85.0522
prevClose
89.52
avgVolume10
1102705
avgVolume20
1353278
changePercent
-0.32
avgVolumeForScore
1353278
ma_cross
ma20
87.5045
ma50
85.0522
rule
Cursor_18.24 MA20/MA50 cross
cross
多頭
score
4
prevMa20
87.336
prevMa50
84.8166
spreadPct
2.88
isVolumeBreakout
false
bollinger
lower
83.3904
upper
91.6186
position
上半部
rsi_short
value
63.79
macd_short
macd
0
trend
中性
signal
0
histogram
0
volume_ratio
ratio
0.61
Raw calculation JSON
{
"risk": {
"level": "Medium",
"reason": "risk management score >= 6.5/10",
"position": {
"score": 1.4,
"details": {
"atrPct": 2.5572117001008627,
"turnoverUsdM": 73.6281345,
"liquidityPoints": 0.4,
"volatilityPoints": 1
}
},
"rrPoints": 1.6,
"stopLevels": {
"symbol": "US.HSIC",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 84.6664,
"strength_details": {
"ma_score": 1.5,
"atr_score": 2,
"rsi_score": 3,
"macd_score": 3,
"volume_score": 1
},
"market_adjustment": 1,
"risk_reward_ratio": 1.6,
"stop_loss_percent": 5.1,
"take_profit_price": 96.4253,
"target_multiplier": 2.2,
"technical_strength": 2.15,
"take_profit_percent": 8.1
},
"positionPoints": 1.4,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.5837562450696818,
"stopLossPercent": 5.1144234002017255,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 66,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 61,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 5
},
"market": {
"ma20": 87.5045,
"ma50": 85.0522,
"close": 89.23,
"prevClose": 89.52,
"avgVolume20": 1353278,
"volumeRatio": 0.61,
"changePercent": -0.32
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 5,
"details": {
"ret_5d": 0.0005606638259698649,
"max_score": 50,
"max_total": 50,
"raw_total": 5,
"vcp_bonus": 0,
"vol_ratio": 0.6025015698701753,
"ret_points": 4,
"vol_points": 0,
"range_ratio": 0.814649783329592,
"volat_points": 0,
"day_range_pct": 0.01933206320744138,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 0,
"partial_history": false,
"pullback_points": 1,
"breakout_vol_bonus": 0,
"first_breakout_20d": false,
"return_window_days": 5,
"first_breakout_bonus": 0,
"breakout_quality_points": 0
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 66,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 2.3,
"label": "基本面",
"weight": "5/110",
"normalized": 46,
"contribution": 2.3
},
{
"raw": 10,
"label": "資金流",
"weight": "20/110",
"normalized": 50,
"contribution": 10
},
{
"raw": 12,
"label": "市場環境",
"weight": "15/110",
"normalized": 80,
"contribution": 12
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 6.8,
"label": "風險管理",
"weight": "10/110",
"normalized": 68,
"contribution": 6.8
},
{
"raw": 21.9,
"label": "技術信號",
"weight": "30/110",
"normalized": 73,
"contribution": 21.9
},
{
"raw": 6,
"label": "情緒分析",
"weight": "10/110",
"normalized": 60,
"contribution": 6
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "checked",
"standard110": {
"rating": "觀望",
"result": 61,
"details": [
"基本面分析總分: 2.3/5分",
"資金流分析總分: 10/20分",
"市場環境分析總分: 12/15分",
"催化劑分析: 2/20分",
"風險管理總分: 6.8/10分",
"技術信號分析總分: 21.9/30分",
"情緒分析: 6/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 2.3,
"資金流": 10,
"市場環境": 12,
"情緒分析": 6,
"技術信號": 21.9,
"風險管理": 6.8
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 8,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "較差",
"items": {
"pbPoints": 0.4,
"pePoints": 0.2,
"epsPoints": 0,
"roePoints": 0.4,
"debtPoints": 0.4,
"marginPoints": 0,
"turnoverUsdM": 73.6281345,
"volumePoints": 0.5,
"revenuePoints": 0,
"dividendPoints": 0,
"marketCapPoints": 0.4
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "較差",
"items": {
"cmfPoints": 0.8,
"mfiPoints": 2.4,
"obvPoints": 0.8,
"vwapPoints": 4,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.HSIC",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "優秀",
"items": {
"vix": {
"score": 2.4,
"details": {
"source": "twelvedata+fred",
"vixClose": 15.19
}
},
"trend": {
"score": 3.4,
"details": {
"qqq": {
"ma20": 706.2430000000002,
"ma50": 712.98440224,
"name": "QQQ",
"close": 717.51001,
"points": 1.4
},
"spy": {
"ma20": 758.6840022499998,
"ma50": 749.8360044,
"name": "SPY",
"close": 767.45001,
"points": 2
},
"source": "twelvedata+fred"
}
},
"atrPct": 2.5572117001008627,
"atrPoints": 3,
"cciPoints": 3.2,
"vixPoints": 2.4,
"marketTrendPoints": 3.4
}
},
"情緒分析": {
"max": 10,
"grade": "一般",
"items": {
"sentiment": {
"score": 6,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 8,
"negativeHits": 0,
"positiveHits": 4,
"sentimentScoreRaw": 1.2
}
},
"sentimentData": {
"raw": [
{
"id": 141202797,
"url": "https://finnhub.io/api/news?id=13ce48a78662402c8da575e857e238a83c262f9699386bfe1a70946f69834569",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Cloud-based dental software drives margin expansion and record customer growth.",
"category": "company",
"datetime": 1786466698,
"headline": "Henry Schein (HSIC) Q2 2026 Earnings Call Transcript"
},
{
"id": 141175592,
"url": "https://finnhub.io/api/news?id=3ce2efa0a033980499897cbba23f031ed75752404bd62aedd9dbd013c13cbacb",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
"category": "company",
"datetime": 1786369204,
"headline": "Should Value Investors Buy Henry Schein (HSIC) Stock?"
},
{
"id": 141137536,
"url": "https://finnhub.io/api/news?id=ddeba90c97f44d13449db22fa27f761374ca2e34a2f1d31b1902e6b98e9c43ee",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "HSIC vs. SAUHY: Which Stock Is the Better Value Option?",
"category": "company",
"datetime": 1786030803,
"headline": "HSIC or SAUHY: Which Is the Better Value Stock Right Now?"
},
{
"id": 141130014,
"url": "https://finnhub.io/api/news?id=77172b533a558640015e733cb2b41e75a28f7d7f54deecf31c06a5bc3a87a165",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein, Inc. reported past Q2 2026 results with sales rising to US$3,458 million and net income to US$94 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. Importantly for long-term watchers, management also raised its 2026 total sales growth guidance, signaling greater confidence in the company’s operating initiatives and demand trends. Now we’ll examine how Henry Schein’s raised 2026 sales outlook reshapes its existing...",
"category": "company",
"datetime": 1785978772,
"headline": "Should Henry Schein’s Raised 2026 Sales Growth Guidance Require Action From Henry Schein (HSIC) Investors?"
},
{
"id": 141122797,
"url": "https://finnhub.io/api/news?id=b6668726049d5d4ee7e835b96bedc652f6c5701d59f49e0912023e1b5097919d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein (HSIC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
"category": "company",
"datetime": 1785935706,
"headline": "Henry Schein, Inc. (HSIC) Hits Fresh High: Is There Still Room to Run?"
},
{
"id": 141120510,
"url": "https://finnhub.io/api/news?id=acffe16b1c33461b9fbeff72f54a5d2c99b0cc0eb0ecb86a4078f1a3ccdf6b34",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein stock has delivered a 37.5% return over the past year, yet the valuation picture is more mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate indicating the shares may be trading at a sizeable discount while earnings based multiples look closer to fair. Henry Schein's 37.5% one year return suggests investors have already priced in a meaningful improvement in the story, so additional upside may depend on how the fundamentals evolve from here. The leadership...",
"category": "company",
"datetime": 1785924693,
"headline": "Is Henry Schein (HSIC) Still Cheap After A 37% Run?"
},
{
"id": 141112261,
"url": "https://finnhub.io/api/news?id=e39066518f2c949a94d671ac58f6703a4c60fa7f16a334dfd4a70d38f1918c35",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "HSIC",
"summary": "Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call August 4, 2026 8:00 AM EDTCompany ParticipantsGraham Stanley - VP of Investor Relations & Strategic...",
"category": "company",
"datetime": 1785853200,
"headline": "Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call Transcript"
},
{
"id": 141110312,
"url": "https://finnhub.io/api/news?id=01e5837a924347cd1bedd5dda28d8136eee81b885372098288f763d19df0933a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein tops Q2 earnings and revenue estimates as internal sales growth accelerates and management raises its 2026 outlook, lifting shares.",
"category": "company",
"datetime": 1785850380,
"headline": "HSIC Surpasses Q2 Earnings and Revenue Estimates, Stock Climbs"
}
],
"raw_source": [
{
"id": 141204260,
"url": "https://finnhub.io/api/news?id=db58bf0aa8b68ae2fed6dfd6fc95b2a0fbb1d72d2a6aad32521464e16841a36e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein delivered a positive second quarter, with results exceeding Wall Street’s expectations and earning a strong market response. Management attributed the outperformance to accelerating internal sales growth, robust gains in its global dental merchandise segment, and early benefits from value creation initiatives. CEO Frederick Lowery emphasized the company’s success in converting occasional buyers into engaged customers and highlighted strong market share gains, particularly in the U.S",
"category": "company",
"datetime": 1786611180,
"headline": "5 Insightful Analyst Questions From Henry Schein’s Q2 Earnings Call"
},
{
"id": 141202797,
"url": "https://finnhub.io/api/news?id=13ce48a78662402c8da575e857e238a83c262f9699386bfe1a70946f69834569",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Cloud-based dental software drives margin expansion and record customer growth.",
"category": "company",
"datetime": 1786466698,
"headline": "Henry Schein (HSIC) Q2 2026 Earnings Call Transcript"
},
{
"id": 141175592,
"url": "https://finnhub.io/api/news?id=3ce2efa0a033980499897cbba23f031ed75752404bd62aedd9dbd013c13cbacb",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
"category": "company",
"datetime": 1786369204,
"headline": "Should Value Investors Buy Henry Schein (HSIC) Stock?"
},
{
"id": 141137536,
"url": "https://finnhub.io/api/news?id=ddeba90c97f44d13449db22fa27f761374ca2e34a2f1d31b1902e6b98e9c43ee",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "HSIC vs. SAUHY: Which Stock Is the Better Value Option?",
"category": "company",
"datetime": 1786030803,
"headline": "HSIC or SAUHY: Which Is the Better Value Stock Right Now?"
},
{
"id": 141136257,
"url": "https://finnhub.io/api/news?id=2ac3067fffc80a90c223a89613abecd8a0b4b6c6a85b2f2005c4bc46988c158b",
"image": "",
"source": "Benzinga",
"related": "HSIC",
"summary": "Barclays analyst Glen Santangelo maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $86 to $100.",
"category": "company",
"datetime": 1786009168,
"headline": "Barclays Maintains Overweight on Henry Schein, Raises Price Target to $100"
},
{
"id": 141130014,
"url": "https://finnhub.io/api/news?id=77172b533a558640015e733cb2b41e75a28f7d7f54deecf31c06a5bc3a87a165",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein, Inc. reported past Q2 2026 results with sales rising to US$3,458 million and net income to US$94 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. Importantly for long-term watchers, management also raised its 2026 total sales growth guidance, signaling greater confidence in the company’s operating initiatives and demand trends. Now we’ll examine how Henry Schein’s raised 2026 sales outlook reshapes its existing...",
"category": "company",
"datetime": 1785978772,
"headline": "Should Henry Schein’s Raised 2026 Sales Growth Guidance Require Action From Henry Schein (HSIC) Investors?"
},
{
"id": 141136258,
"url": "https://finnhub.io/api/news?id=e4ac95fc7fd92c719b305af361c177558bae5f9e4714dd2327f875f43a516150",
"image": "",
"source": "Benzinga",
"related": "HSIC",
"summary": "UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the price target from $89 to $94.",
"category": "company",
"datetime": 1785944951,
"headline": "UBS Maintains Neutral on Henry Schein, Raises Price Target to $94"
},
{
"id": 141136259,
"url": "https://finnhub.io/api/news?id=05e60f86d98d403bfdda4d0ed7349b566cea35e6ed37d4a252ce2cc736e0602b",
"image": "",
"source": "Benzinga",
"related": "HSIC",
"summary": "Citigroup analyst Daniel Grosslight maintains Henry Schein (NASDAQ:HSIC) with a Buy and raises the price target from $100 to $112.",
"category": "company",
"datetime": 1785941800,
"headline": "Citigroup Maintains Buy on Henry Schein, Raises Price Target to $112"
},
{
"id": 141122797,
"url": "https://finnhub.io/api/news?id=b6668726049d5d4ee7e835b96bedc652f6c5701d59f49e0912023e1b5097919d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein (HSIC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",
"category": "company",
"datetime": 1785935706,
"headline": "Henry Schein, Inc. (HSIC) Hits Fresh High: Is There Still Room to Run?"
},
{
"id": 141120510,
"url": "https://finnhub.io/api/news?id=acffe16b1c33461b9fbeff72f54a5d2c99b0cc0eb0ecb86a4078f1a3ccdf6b34",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein stock has delivered a 37.5% return over the past year, yet the valuation picture is more mixed, with the Discounted Cash Flow (DCF) intrinsic value estimate indicating the shares may be trading at a sizeable discount while earnings based multiples look closer to fair. Henry Schein's 37.5% one year return suggests investors have already priced in a meaningful improvement in the story, so additional upside may depend on how the fundamentals evolve from here. The leadership...",
"category": "company",
"datetime": 1785924693,
"headline": "Is Henry Schein (HSIC) Still Cheap After A 37% Run?"
},
{
"id": 141123305,
"url": "https://finnhub.io/api/news?id=ca3dc88e5b266a9bf638da0afc89f49d6eb425b6e4cf1382c99239c6ca409d99",
"image": "",
"source": "Benzinga",
"related": "HSIC",
"summary": "BTIG analyst David Larsen reiterates Henry Schein (NASDAQ:HSIC) with a Buy and maintains $100 price target.",
"category": "company",
"datetime": 1785910507,
"headline": "BTIG Reiterates Buy on Henry Schein, Maintains $100 Price Target"
},
{
"id": 141120511,
"url": "https://finnhub.io/api/news?id=8ae2ad59bc13ad7da2ba186d561098d1982cc1b6ce262d5eb5abac78a8dc4fa6",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Moby summary of Henry Schein, Inc.'s Q2 2026 earnings call",
"category": "company",
"datetime": 1785895753,
"headline": "Henry Schein, Inc. Q2 2026 Earnings Call Summary"
},
{
"id": 141118414,
"url": "https://finnhub.io/api/news?id=557878f7486aae6f59d5dbbfd9147accc4ff362ed8b242eb402d6d811e268cff",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "HSIC",
"summary": "2026-08-05. The following slide deck was published by Henry Schein, Inc.",
"category": "company",
"datetime": 1785891777,
"headline": "Henry Schein, Inc. 2026 Q2 - Results - Earnings Call Presentation"
},
{
"id": 141112071,
"url": "https://finnhub.io/api/news?id=41789a061b6b09b1b44b9d2c1b4bb5d8baaa4320e5fd430f67f115d56fd21fcc",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein (NASDAQ:HSIC) reported higher second-quarter sales, operating margins and earnings, citing accelerating internal sales growth, market-share gains in dental merchandise and early benefits from its value-creation program. The company also raised its full-year sales and adjusted earnings g",
"category": "company",
"datetime": 1785859466,
"headline": "Henry Schein Q2 Earnings Call Highlights"
},
{
"id": 141112261,
"url": "https://finnhub.io/api/news?id=e39066518f2c949a94d671ac58f6703a4c60fa7f16a334dfd4a70d38f1918c35",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "HSIC",
"summary": "Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call August 4, 2026 8:00 AM EDTCompany ParticipantsGraham Stanley - VP of Investor Relations & Strategic...",
"category": "company",
"datetime": 1785853200,
"headline": "Henry Schein, Inc. (HSIC) Q2 2026 Earnings Call Transcript"
},
{
"id": 141110312,
"url": "https://finnhub.io/api/news?id=01e5837a924347cd1bedd5dda28d8136eee81b885372098288f763d19df0933a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein tops Q2 earnings and revenue estimates as internal sales growth accelerates and management raises its 2026 outlook, lifting shares.",
"category": "company",
"datetime": 1785850380,
"headline": "HSIC Surpasses Q2 Earnings and Revenue Estimates, Stock Climbs"
},
{
"id": 141110366,
"url": "https://finnhub.io/api/news?id=90cf0c669ec0caf39e573b66bb0383e2eb51f01348b0568fdbfaac3e2a33284c",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "While the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
"category": "company",
"datetime": 1785850203,
"headline": "Henry Schein (HSIC) Reports Q2 Earnings: What Key Metrics Have to Say"
},
{
"id": 141107921,
"url": "https://finnhub.io/api/news?id=5ed00d970d9f0623f40e952eaccbc30ab883a5a63b0952a1a0980a6637262f64",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.",
"category": "company",
"datetime": 1785844642,
"headline": "3 S&P 500 Stocks Walking a Fine Line"
},
{
"id": 141107588,
"url": "https://finnhub.io/api/news?id=c861068787cab33bfc4419a04ef8d56e040c452e849c754656552f61bcab932e",
"image": "https://www.chartmill.com/images/uploads/earnings_article_1_defce97180.webp",
"source": "ChartMill",
"related": "HSIC",
"summary": "Henry Schein Q2 2026: EPS $1.27 beats estimates, revenue $3.46B up 6.7%, raises full-year guidance. Stock up 1.8% premarket.",
"category": "company",
"datetime": 1785843439,
"headline": "Henry Schein (NASDAQ:HSIC) Beats Q2 Estimates and Raises Full-Year Guidance"
},
{
"id": 141108854,
"url": "https://finnhub.io/api/news?id=eec0907e2f8b9c8eb9e3bed6f2d93340eec0da9481493f546717a71608474488",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein (HSIC) delivered earnings and revenue surprises of +4.10% and +2.80%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
"category": "company",
"datetime": 1785841801,
"headline": "Henry Schein (HSIC) Q2 Earnings and Revenues Beat Estimates"
},
{
"id": 141107939,
"url": "https://finnhub.io/api/news?id=676413998ce0f02b1d2d360a1d97681185994ce9f2e02828d88d3de1c5890677",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Dental and medical products company Henry Schein (NASDAQ:HSIC) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 6.7% year on year to $3.46 billion. Its non-GAAP profit of $1.27 per share was 2.5% above analysts’ consensus estimates.",
"category": "company",
"datetime": 1785839077,
"headline": "Henry Schein (NASDAQ:HSIC) Surprises With Q2 CY2026 Sales"
},
{
"id": 141107940,
"url": "https://finnhub.io/api/news?id=f94997c1f7c9e609f6893e53e19a861d39af7446d9f767538e7e896a24f29ab4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "MELVILLE, N.Y., August 04, 2026--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, today reported financial results for the second quarter ended June 27, 2026.",
"category": "company",
"datetime": 1785837600,
"headline": "Henry Schein Reports Strong Second Quarter 2026 Financial Results and Raises FY2026 Guidance"
},
{
"id": 141116542,
"url": "https://finnhub.io/api/news?id=09e880cb97959b7248932339f244738b136e5c0cb2eedda3e6b4be323ab34735",
"image": "https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "HSIC",
"summary": "Henry Schein (NASDAQ:HSIC) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below.\nThis transcript is brought to you by Benzinga",
"category": "company",
"datetime": 1785834549,
"headline": "Henry Schein Q2 2026 Earnings Call: Complete Transcript"
},
{
"id": 141116543,
"url": "https://finnhub.io/api/news?id=fc97cafb9c7e98e1afcace4df2980cfabcb2d7c41fac77843d9b4d8a1de82304",
"image": "",
"source": "Benzinga",
"related": "HSIC",
"summary": "Henry Schein (NASDAQ:HSIC) raises FY2026 Adj EPS guidance from $5.23-$5.37 to $5.29-$5.39 vs $5.33 analyst estimate. Raises FY2026 sales outlook from $13.580 billion-$13.843 billion to $13.794 billion-$13.926 billion vs",
"category": "company",
"datetime": 1785823514,
"headline": "Henry Schein Raises FY2026 Adj EPS Guidance from $5.23-$5.37 to $5.29-$5.39 vs $5.33 Est; Raises FY2026 Sales Guidance from $13.580B-$13.843B to $13.794B-$13.926B vs $13.738B Est"
},
{
"id": 141116544,
"url": "https://finnhub.io/api/news?id=dc4e8d00225fe5bbde0f1c899da2bc19fa7b2d90cdf615283c90683b5a06f864",
"image": "",
"source": "Benzinga",
"related": "HSIC",
"summary": "Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $1.24 by 2.42 percent. This is a 15.45 percent increase over earnings of $1.10 per share from the",
"category": "company",
"datetime": 1785823297,
"headline": "Henry Schein Q2 Adj. EPS $1.27 Beats $1.24 Estimate, Sales $3.458B Beat $3.375B Estimate"
},
{
"id": 141101308,
"url": "https://finnhub.io/api/news?id=97838c038fecc1a81315b3fe6317961a8bfe1e074edbb7dc2969eb4c6bfa10d0",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Dental and medical products company Henry Schein (NASDAQ:HSIC) will be reporting results this Tuesday before the bell. Here’s what you need to know.",
"category": "company",
"datetime": 1785768802,
"headline": "Henry Schein (HSIC) Reports Q2: Everything You Need To Know Ahead Of Earnings"
},
{
"id": 141101309,
"url": "https://finnhub.io/api/news?id=77217be39d97dcea8961e6629a034c6e95329e6a3a5ff364fafcfceb0ce4fa8b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "The reorganization comes months after Fred Lowery was named CEO and the company deepened its relationship with private equity firm KKR.",
"category": "company",
"datetime": 1785747600,
"headline": "Henry Schein removes 3 longtime execs in leadership shakeup"
},
{
"id": 141077229,
"url": "https://finnhub.io/api/news?id=e08362b1d1e763cf9db2c126b7646e46b8ad53c9c194f5f689f9cc18ae6f07b0",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.",
"category": "company",
"datetime": 1785495335,
"headline": "1 Cash-Producing Stock to Target This Week and 2 We Question"
},
{
"id": 141064771,
"url": "https://finnhub.io/api/news?id=3c8576f4ec21ec742c43320948e5981ba5f156bb1cb19ebdc53660d695e39f6a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "MELVILLE, N.Y., July 30, 2026--Henry Schein, Inc. (Nasdaq: HSIC) announced today that it is creating the Henry Schein Leadership Team (HSLT) to replace its Executive Management Committee. The Company will also integrate its global supply chain organization with its global distribution group. The new leadership structure will continue to develop the Company’s strategic priorities, accelerate its execution, and enhance enterprise collaboration.",
"category": "company",
"datetime": 1785409200,
"headline": "Henry Schein Announces Leadership Transitions"
},
{
"id": 141059462,
"url": "https://finnhub.io/api/news?id=02a3f8e041d7c6cc2c5c79b5553e74a1ede0c3508a8071c4ee0b60b4a59c2c42",
"image": "",
"source": "Benzinga",
"related": "HSIC",
"summary": "Piper Sandler analyst Jason Bednar maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $91 to $95.",
"category": "company",
"datetime": 1785330948,
"headline": "Piper Sandler Maintains Overweight on Henry Schein, Raises Price Target to $95"
},
{
"id": 141050021,
"url": "https://finnhub.io/api/news?id=bbaca5dd00a9e9ab05fb272a223cb8e7e5f25c3f79cdafba535b20fdb4e9fa96",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment & technology stocks, including Henry Schein (NASDAQ:HSIC) and its peers.",
"category": "company",
"datetime": 1785291182,
"headline": "Q1 Earnings Roundup: Henry Schein (NASDAQ:HSIC) And The Rest Of The Dental Equipment & Technology Segment"
},
{
"id": 141047793,
"url": "https://finnhub.io/api/news?id=7ae08794ee9e1fc9d1e7f8597107a075636e00d89d8e77d9da8f39251a9052c9",
"image": "",
"source": "Benzinga",
"related": "HSIC",
"summary": "UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the price target from $85 to $89.",
"category": "company",
"datetime": 1785252144,
"headline": "UBS Maintains Neutral on Henry Schein, Raises Price Target to $89"
},
{
"id": 141043753,
"url": "https://finnhub.io/api/news?id=26ad68828352e6c29c891a3dfad45b0b89d2bac7a4cc44630baee9cb00c94ea1",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "HSIC heads into Q2 earnings with expectations for revenue and EPS growth as dental, specialty products and AI-enabled technology remain in focus.",
"category": "company",
"datetime": 1785245100,
"headline": "Henry Schein Prepares to Report Q2 Earnings: What's in the Cards?"
},
{
"id": 141033957,
"url": "https://finnhub.io/api/news?id=f9c77f2c7a2b30fa8a6e2c19700b09a28d1482789e3ac5a2c0c0cc32cff09d93",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "A steadily shrinking share count and a giant float owed to suppliers are handing owners a bigger slice of the drug distributor each year, even as drug-pricing worries hang over the stock.",
"category": "company",
"datetime": 1785160469,
"headline": "The Buyback Machine Hiding Behind Cardinal Health's Thin Margins"
},
{
"id": 140995071,
"url": "https://finnhub.io/api/news?id=8ffc06d98842cfd9894bec94cc65023b1ec1025c6d7b2ceec3f56a00f5bf4ed5",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.",
"category": "company",
"datetime": 1784814004,
"headline": "Are Investors Undervaluing Henry Schein (HSIC) Right Now?"
},
{
"id": 140986483,
"url": "https://finnhub.io/api/news?id=1fe8f85feaaf866d3f6cd77cac66408d824c381cab208ebb46ea6a8ae7f4e72e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Upcoming earnings release puts focus on Henry Schein stock Henry Schein (HSIC) is back on investors’ radar after announcing it will report second quarter 2026 results before the market opens on August 4, followed by an earnings conference call and webcast. See our latest analysis for Henry Schein. Henry Schein’s recent share price performance has been firmer over the past few months, with a 30 day share price return of 7.43% and a year to date share price return of 11.77%. Meanwhile, the 1...",
"category": "company",
"datetime": 1784747591,
"headline": "Henry Schein (HSIC) Could Be 3% Undervalued As Earnings Come Into Focus"
},
{
"id": 140981940,
"url": "https://finnhub.io/api/news?id=4ef76ce27eda81d626046a0e4578b307154512d58d22f0a60cb0d85499f4330a",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "LH heads into Q2 earnings results with expectations for higher revenues and EPS, as diagnostics, specialty testing and new collaborations drive momentum.",
"category": "company",
"datetime": 1784723820,
"headline": "Labcorp Prepares to Report Q2 Earnings: What's in the Cards?"
},
{
"id": 140973539,
"url": "https://finnhub.io/api/news?id=fc59b28a72e9fb67c5de58ff9b6deef6c4e9908ebb0d5136f53ed8bdb8d7d728",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "WST heads into Q2 earnings with expectations for revenue and EPS growth, backed by demand for biologics and GLP-1 components plus manufacturing gains.",
"category": "company",
"datetime": 1784647920,
"headline": "WST Likely to Beat Q2 Earnings Estimates: How to Play the Stock?"
},
{
"id": 140969661,
"url": "https://finnhub.io/api/news?id=9c574e32d1ba87de743c163a5271f334521271294051559f0208df02fabb9c3b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "MELVILLE, N.Y., July 21, 2026--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its second quarter 2026 financial results before the stock market opens on Tuesday, August 4, 2026, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Fred Lowery, Chief Executive Officer and Ro",
"category": "company",
"datetime": 1784629800,
"headline": "Henry Schein to Webcast Second Quarter 2026 Conference Call on Tuesday, August 4, 2026, at 8:00 a.m. ET"
},
{
"id": 140962334,
"url": "https://finnhub.io/api/news?id=7cc55104ec9bbc22bbb01fb63ee5ed86574ce6c621c24e9538c50ee030e79d77",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "HSIC",
"summary": "Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
"category": "company",
"datetime": 1784563804,
"headline": "Will Henry Schein (HSIC) Beat Estimates Again in Its Next Earnings Report?"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 8,
"negative_hits": 0,
"positive_hits": 4,
"recomputed_at_score": true,
"sentiment_score_raw": 1.2,
"source_article_count": 40,
"discarded_article_count": 23
},
"sentimentPoints": 6
}
},
"技術信號": {
"max": 30,
"raw": 21.9,
"grade": "良好",
"items": {
"bbPoints": 3,
"adxPoints": 3,
"sarPoints": 2.4000000000000004,
"vcpPoints": 2.2,
"macdPoints": 4,
"vcpPayload": {
"vcp_pass": false,
"vcp_score": 2.2,
"vcp_reason": "波幅收縮(11%→5.7%)；跌縮量(近10日5日)；站上MA50；Ready=Y；Confirm=N",
"vcp_metrics": {
"up_days": 3,
"vol_ref": 1344923.3333333333,
"down_days": 6,
"vcp_ready": true,
"above_ma50": true,
"avg_vol_10": 1356270,
"avg_vol_20": 1369540,
"avg_vol_30": 1344923.3333333333,
"range_pct_10": 0.05737982741230543,
"range_pct_20": 0.10075086854197028,
"range_pct_30": 0.11027681273114427,
"up_expand_ok": false,
"lookback_used": 59,
"near_20d_high": true,
"contraction_ok": true,
"down_shrink_ok": true,
"up_expand_days": 1,
"breakout_20d_ok": false,
"vol_ratio_10_30": 1.0084366642956104,
"dist_to_20d_high": 0.03200260360164898,
"down_shrink_days": 5,
"breakout_level_20d": 92.18,
"vcp_breakout_confirm": false,
"contraction_ratio_10_30": 0.5203254065040662
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": true
},
"kdjAdxPoints": 0.5,
"rsiKdjPoints": 2.4,
"volumeWeight": 2,
"maCrossPoints": 1.6,
"shortRsiPoints": 1,
"shortMacdPoints": 0.4,
"volConfirmPoints": 1,
"volumePointsTechnical": 0.4
}
},
"風險管理": {
"max": 10,
"grade": "一般",
"items": {
"position": {
"score": 1.4,
"details": {
"atrPct": 2.5572117001008627,
"turnoverUsdM": 73.6281345,
"liquidityPoints": 0.4,
"volatilityPoints": 1
}
},
"rrPoints": 1.6,
"stopLevels": {
"symbol": "US.HSIC",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 84.6664,
"strength_details": {
"ma_score": 1.5,
"atr_score": 2,
"rsi_score": 3,
"macd_score": 3,
"volume_score": 1
},
"market_adjustment": 1,
"risk_reward_ratio": 1.6,
"stop_loss_percent": 5.1,
"take_profit_price": 96.4253,
"target_multiplier": 2.2,
"technical_strength": 2.15,
"take_profit_percent": 8.1
},
"positionPoints": 1.4,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.5837562450696818,
"stopLossPercent": 5.1144234002017255,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": true,
"missingFields": [],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 85.71,
"atr": {
"atr": 2.2818,
"rule": "ATR / current price; lower volatility scores higher",
"score": 6,
"atr_pct": 2.56
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "適中偏強",
"score": 8,
"value": 67.97
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "派發",
"score": 2,
"value": -0.0233
},
"kdj": {
"d": 59.29,
"j": 44.43,
"k": 54.34,
"rule": "Cursor_18.24 K/D cross",
"score": 0,
"signal": "死叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "平衡",
"score": 6,
"value": 50.47
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 2,
"trend": "資金流出",
"value": 17269850,
"recentSlope": -545175,
"previousSlope": 915630
},
"rsi": 65.8,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 8,
"trend": "上升",
"value": 86.2635,
"position": "SAR喺價下",
"distancePct": 3.32,
"previousTrend": "上升"
},
"ma50": 85.0522,
"macd": {
"macd": 1.4490597923500559,
"trend": "強烈看漲",
"signal": 1.4386863064582798,
"histogram": 0.010373485891776113
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 10,
"value": 87.5053,
"position": "連續5日>VWAP",
"consecutiveAbove": 12
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "空升",
"ratio": 0.61,
"score": 2,
"avgVolume": 1353278,
"currentVolume": 825150
},
"derived": {
"ma20": 87.5045,
"ma50": 85.0522,
"prevClose": 89.52,
"avgVolume10": 1102705,
"avgVolume20": 1353278,
"changePercent": -0.32,
"avgVolumeForScore": 1353278
},
"ma_cross": {
"ma20": 87.5045,
"ma50": 85.0522,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "多頭",
"score": 4,
"prevMa20": 87.336,
"prevMa50": 84.8166,
"spreadPct": 2.88,
"isVolumeBreakout": false
},
"bollinger": {
"lower": 83.3904,
"upper": 91.6186,
"position": "上半部"
},
"rsi_short": 63.79,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 0.61
}
}
}
Raw metrics JSON
{
"close": 89.23,
"volume": 825150,
"changePercent": -0.32
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.